Work

Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies

Year: 2010

Type: article

Study design: Clinical Trial

Source: Alimentary Pharmacology & Therapeutics

DOI: 10.1111/j.1365-2036.2010.04516.x

Authors: L. Laine, P. O. Katz, D. A. Johnson, I. Ibegbu, M. J. Goldstein, C. Chou, G. Rossiter, Y. Lu

Institutions: University of Southern California, Jefferson Einstein Philadelphia Hospital, Eastern Virginia Medical School, Eisai (United States)

Language: English

Topic: Gastroesophageal reflux and treatments

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Eisai

OpenAlex ID: W1598354629

FWCI: 3.758

Cites: 26

Cited by: 30

Related to: 10